Kinetic low-dose antibody depletion of Treg cell can generate anti-tumor immunity by enhancing the pro-inflammatory cytokines and the anti-tumor effector lymphocytes, including antigen-specific IFN-γ-secreting CD8+ T cells (Fig. 6A–6C). Here, CD8A is linked to neoplasm.